Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inh...

2026-01-20

Anlotinib hydrochloride is a potent multi-target tyrosine kinase inhibitor, optimized for inhibition of VEGFR2, PDGFRβ, and FGFR1 in preclinical anti-angiogenic research. Compared to other TKIs, it exhibits superior selectivity, robust endothelial cell migration inhibition, and favorable pharmacokinetics, making it a benchmark tool for tumor angiogenesis studies.